NCT05974410 - Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients | Biotech Hunter

Timeline

Start Date

Not specified

Conditions

GlioblastomaSquamous Cell CarcinomaHodgkin LymphomaNon-hodgkin LymphomaBreast CancerProstate CancerGastric CancerOvarian CancerAcute LeukemiaPancreatic CancerSpindle Cell SarcomaCancerTumor, SolidTumor, BrainEsophageal AndeocarcinomaMixed Phenotype AMLDesmoplastic Round Cell Sarcoma

Interventions

DRUG

AVM0703

small molecule immunomodulatory drug

DRUG

Hydrocortisone

physiologic circadian glucocorticoid

DRUG

Proton pump inhibitor